Aryeh Jason — SEC Form 4 filings
SEC reporting owner CIK 1376960. 20 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-03-06 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 10,636 shares, $39,931 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 15,000 shares, $2,958,088 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 4,500 shares @ $250.00 ($1,125,000) in LIGAND PHARMACEUTICALS INC, filed 2026-06-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC (LGND) | Director | 7 | — | 5 legs · 15,000 sh · $2,958,088 | 12 |
| Orchestra BioMed Holdings, Inc. (OBIO) | Director | 8 | 3 legs · 10,636 sh · $39,931 | — | 8 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | Director | 2 | — | — | 4 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Director | 3 | — | — | 3 |
Form 4 filings — Aryeh Jason
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 42,553 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 836 @ $0 · Sale (S): 500 @ $250 · Sale (S): 4,500 @ $250 · Grant/award (A): 2,938 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/award (A): 25,907 | EDGAR |
| 2026-05-20 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Purchase (P): 665 @ $3.75 | EDGAR |
| 2026-05-19 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Purchase (P): 8,971 @ $3.90 | EDGAR |
| 2025-12-08 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,034 @ $69.51 · Option exercise (M): 2,034 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Sale (S): 4,418 @ $170.41 · Sale (S): 4,628 @ $170.96 · Sale (S): 954 @ $171.92 | EDGAR |
| 2025-09-19 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Purchase (P): 1,000 @ $2.45 | EDGAR |
| 2025-08-08 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2025-07-17 | 4 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/award (A): 19,506 | EDGAR |
| 2025-06-27 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 12,422 @ $0 · Grant/award (A): 36,797 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 1,209 @ $0 · Grant/award (A): 5,783 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Anebulo Pharmaceuticals, Inc. (ANEB) | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 4,964 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Option exercise (M): 11,700 @ $4.30 · Option exercise (M): 11,700 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/award (A): 24,554 | EDGAR |
| 2024-06-21 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) | Grant/award (A): 5,376 @ $0 · Grant/award (A): 17,068 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 1,252 @ $0 · Grant/award (A): 5,444 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Anebulo Pharmaceuticals, Inc. (ANEB) | Grant/award (A): 41,667 (derivative) @ $0 · Grant/award (A): 2,482 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,406 @ $52.30 · Option exercise (M): 2,406 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,893 @ $39.35 · Option exercise (M): 2,893 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376960 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →